Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript

BIOMIMETIC THERAPEUTICS, INC. (BMTI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/19/2011 BW The Shuman Law Firm Investigates BioMimetic Therapeutics, Inc.
07/11/2011 BW Robbins Umeda LLP Announces an Investigation of BioMimetic Therapeutics, Inc.
06/20/2011 BW Bronstein, Gewirtz & Grossman, LLC Investigates BioMimetic Therapeutics Inc.
06/20/2011 BW BioMimetic Therapeutics, Inc. to Present at the Wells Fargo 2011 Healthcare Conference
06/06/2011 BW BioMimetic Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
05/12/2011 BW BioMimetic Therapeutics' Augment??? Bone Graft Receives Positive Recommendation from FDA Advisory Committee
05/09/2011 BW BioMimetic Therapeutics, Inc. Reports First Quarter 2011 Earnings Results
05/02/2011 BW BioMimetic Therapeutics, Inc. to Present at the Deutsche Bank Healthcare Conference
03/29/2011 BW BioMimetic Therapeutics Augment™ Bone Graft Advisory Panel Meeting Date Published in Federal Register
03/10/2011 BW BioMimetic Therapeutics, Inc. Reports 2010 Fourth Quarter and Year End Earnings Results
03/08/2011 BW BioMimetic Therapeutics to Report 2010 Fourth Quarter and Year-End Financial Results on March 10
02/17/2011 BW BioMimetic Therapeutics, Inc. Highlights Commercial and Product Development Activities during AAOS
11/03/2010 BW BioMimetic Therapeutics, Inc. Reports 2010 Third Quarter Earnings Results
11/01/2010 BW BioMimetic Therapeutics to Report 2010 Third Quarter Results on November 3
10/01/2010 BW BioMimetic Therapeutics, Inc. to Present at the 2010 William Blair Emerging Growth Stock Conference
08/12/2010 BW BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteochondritis Dissecans
08/03/2010 BW BioMimetic Therapeutics to Report 2010 Second Quarter Results on August 5
07/20/2010 BW BioMimetic Therapeutics Announces Closing of Public Offering and Exercise of Over-Allotment Option
07/14/2010 BW BioMimetic Therapeutics, Inc. Prices Public Offering of Common Stock
07/12/2010 BW BioMimetic Therapeutics, Inc. Announces Commencement of Public Offering of Common Stock
07/07/2010 BW BioMimetic Therapeutics, Inc. Releases Clinical Update Including Positive 52-Week Data from North American Pivotal Trial
07/01/2010 BW BioMimetic Therapeutics, Inc. to Present Final Data from Augment™ Bone Graft Pivotal Trial at AOFAS Summer Meeting
06/28/2010 BW BioMimetic Therapeutics Receives Filing Letter from FDA for Augment™ Bone Graft PMA
06/22/2010 BW BioMimetic Therapeutics, Inc. to Present at the 2010 Wells Fargo Securities Healthcare Conference
06/07/2010 BW BioMimetic Therapeutics, Inc. to Present at the Jefferies Global Life Sciences Conference
05/10/2010 BW BioMimetic Therapeutics Reports 2010 First Quarter Earnings Results
05/07/2010 BW BioMimetic Therapeutics, Inc. to Present at the Bank of America Merrill Lynch 2010 Healthcare Conference
05/06/2010 BW BioMimetic Therapeutics to Report 2010 First Quarter on May 10
04/29/2010 BW BioMimetic Therapeutics, Inc. to Present at the Deutsche Bank 35th Annual Healthcare Conference
03/11/2010 BW BioMimetic Therapeutics Reports 2009 Fourth Quarter and Year End Earnings Results
03/09/2010 BW BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting
03/04/2010 BW BioMimetic Therapeutics, Inc. to Highlight Pre-Clinical and Clinical Activities at ORS and AAOS Meetings
02/17/2010 BW BioMimetic Therapeutics Completes Submission of PMA Application for FDA Approval of Augment™ Bone Graft

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy